United Purification Technology Co., Ltd. (6977.TWO)
TWD 45.0
(0.0%)
TWD 45.0
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Operating Cash Flow | 73.03 Million | -50.46 Million | 87.23 Million | 69.69 Million |
| Net Income | 47.78 Million | 123.5 Million | 149.79 Million | 20.51 Million |
| Depreciation & Amortization | 8.91 Million | 8.23 Million | 6.97 Million | 4.21 Million |
| Deferred income taxes | - | - | - | - |
| Stock-based compensation | - | - | - | - |
| Change in working capital | 74.44 Million | -170.83 Million | -53.67 Million | 29.47 Million |
| Other non-cash items | 4.38 Million | 5.04 Million | -1.6 Million | 15.48 Million |
| Investing Cash Flow | -30.66 Million | -31.96 Million | -54.71 Million | -725 Thousand |
| Investments in PPE | -64.83 Million | -1.19 Million | -2.46 Million | -934 Thousand |
| Acquisitions | 137 Thousand | - | -30.13 Million | - |
| Investment purchases | - | -34.19 Million | -10.08 Million | - |
| Sales/Maturities of investments | 37.73 Million | - | - | - |
| Other Investing Activities | -3.69 Million | 3.42 Million | -12.27 Million | 209 Thousand |
| Financing Cash Flow | 150.95 Million | 70.25 Million | -10.91 Million | -57.3 Million |
| Debt repayment | -65.13 Million | -32.65 Million | -10.08 Million | -19 Million |
| Dividends payments | -20 Million | -16 Million | -15.79 Million | - |
| Common Stock Repurchased | -22.75 Million | - | - | - |
| Common Stock Issuance | 136 Million | 60 Million | - | - |
| Other Financing Activities | 186.37 Million | 88.97 Million | 13.31 Million | -76.3 Million |
| Accounts receivables | 180.9 Million | -225.2 Million | -69.95 Million | 42.4 Million |
| Accounts payables | -61.13 Million | - | - | - |
| Inventory | -5.83 Million | -2.99 Million | 10.73 Million | -1.92 Million |
| Other working capital | -4.81 Million | -7.14 Million | 11.72 Million | -10.99 Million |
| Cash at beginning of period | 58.48 Million | 68.2 Million | 47.03 Million | 34.39 Million |
| Cash at end of period | 269.36 Million | 58.48 Million | 68.2 Million | 47.03 Million |
| Capital Expenditure | -64.83 Million | -1.19 Million | -2.46 Million | -934 Thousand |
| Effect of forex changes on cash | 17.55 Million | 2.45 Million | -442 Thousand | 976 Thousand |
| Net cash flow / Change in cash | 210.88 Million | -9.72 Million | 21.16 Million | 12.64 Million |
| Free Cash Flow | 8.2 Million | -51.65 Million | 84.77 Million | 68.76 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -7.25 Million | -7.25 Million | 7.68 Million | 47.78 Million | 7.68 Million | 4.13 Million |
| Depreciation & Amortization | 3.14 Million | 3.14 Million | 2.24 Million | 8.91 Million | 2.24 Million | 2.11 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 29.18 Million | 29.18 Million | 32.13 Million | 74.44 Million | 32.13 Million | 52.99 Million |
| Other non-cash items | -9.77 Million | -9.77 Million | -22.56 Million | 4.38 Million | -22.56 Million | -42.21 Million |
| Investing Cash Flow | 3.62 Million | 3.62 Million | -13.51 Million | -30.66 Million | -13.51 Million | -1.81 Million |
| Investments in PPE | -6.58 Million | -6.58 Million | -31.77 Million | -64.83 Million | -31.77 Million | -508.49 Thousand |
| Acquisitions | 252 Thousand | - | - | - | - | - |
| Investment purchases | -3.4 Million | - | - | - | - | - |
| Sales/Maturities of investments | 23.14 Million | - | - | 37.73 Million | - | - |
| Other Investing Activities | 10.21 Million | 10.21 Million | 18.25 Million | -3.69 Million | 18.25 Million | -1.31 Million |
| Financing Cash Flow | 13.35 Million | 13.35 Million | 47.7 Million | 150.95 Million | 47.7 Million | 27.77 Million |
| Debt repayment | -31.16 Million | - | - | -65.13 Million | - | - |
| Dividends payments | - | - | -10 Million | -20 Million | -10 Million | - |
| Common Stock Repurchased | -131 Thousand | -131 Thousand | -11.37 Million | -22.75 Million | -11.37 Million | - |
| Common Stock Issuance | - | - | - | 136 Million | - | - |
| Other Financing Activities | 13.48 Million | 13.48 Million | 69.08 Million | 186.37 Million | 69.08 Million | 27.77 Million |
| Accounts receivables | 45.54 Million | 45.54 Million | 11.6 Million | 180.9 Million | 11.6 Million | 78.84 Million |
| Accounts payables | -6.84 Million | - | - | - | - | - |
| Inventory | 807 Thousand | 807 Thousand | -561 Thousand | -5.83 Million | -561 Thousand | -2.35 Million |
| Other working capital | -17.16 Million | -17.16 Million | 21.09 Million | -4.81 Million | 21.09 Million | -23.49 Million |
| Cash at beginning of period | 269.36 Million | - | - | 58.48 Million | - | - |
| Cash at end of period | 37.61 Million | 37.61 Million | 65.33 Million | 269.36 Million | 65.33 Million | 40.1 Million |
| Capital Expenditure | -6.58 Million | -6.58 Million | -31.77 Million | -64.83 Million | -31.77 Million | -508.49 Thousand |
| Effect of forex changes on cash | 5.33 Million | 5.33 Million | 11.64 Million | 17.55 Million | 11.64 Million | -2.87 Million |
| Net cash flow / Change in cash | -231.74 Million | 37.61 Million | 65.33 Million | 210.88 Million | 65.33 Million | 40.1 Million |
| Free Cash Flow | 8.7 Million | 8.7 Million | -12.27 Million | 8.2 Million | -12.27 Million | 16.51 Million |
NUCLEUS
301122
1640
8143
RAASY
MGT